ATE487800T1 - Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion - Google Patents

Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion

Info

Publication number
ATE487800T1
ATE487800T1 AT06807950T AT06807950T ATE487800T1 AT E487800 T1 ATE487800 T1 AT E487800T1 AT 06807950 T AT06807950 T AT 06807950T AT 06807950 T AT06807950 T AT 06807950T AT E487800 T1 ATE487800 T1 AT E487800T1
Authority
AT
Austria
Prior art keywords
ovarian
ovarian function
vitro detection
presidency
predisposition
Prior art date
Application number
AT06807950T
Other languages
English (en)
Inventor
Francisco J Moran
Jose L Royo
Maria Eugenia Saez
Luis Miguel Real
Agustin Ruiz
Original Assignee
Neocodex S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neocodex S L filed Critical Neocodex S L
Application granted granted Critical
Publication of ATE487800T1 publication Critical patent/ATE487800T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/362Menopause
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/367Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Semiconductor Memories (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
AT06807950T 2005-09-13 2006-08-29 Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion ATE487800T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200502225 2005-09-13
PCT/ES2006/070130 WO2007031590A1 (es) 2005-09-13 2006-08-29 Método de detección in vitro de la predisposición a desarrollar alteraciones en la función ovárica

Publications (1)

Publication Number Publication Date
ATE487800T1 true ATE487800T1 (de) 2010-11-15

Family

ID=37864641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06807950T ATE487800T1 (de) 2005-09-13 2006-08-29 Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion

Country Status (5)

Country Link
US (1) US20100203502A1 (de)
EP (1) EP1947195B1 (de)
AT (1) ATE487800T1 (de)
DE (1) DE602006018183D1 (de)
WO (1) WO2007031590A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201405883XA (en) * 2009-09-23 2014-11-27 Celmatix Inc Methods and devices for assessing infertility and/or egg quality
US10162800B2 (en) 2012-10-17 2018-12-25 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9836577B2 (en) 2012-12-14 2017-12-05 Celmatix, Inc. Methods and devices for assessing risk of female infertility
KR101565886B1 (ko) 2013-10-23 2015-11-05 전남대학교산학협력단 난소과자극증후군의 진단 방법 및 키트
KR20170063519A (ko) 2014-07-17 2017-06-08 셀매틱스, 인크. 불임 및 관련 병리상태를 평가하기 위한 방법 및 시스템
JP2019503191A (ja) * 2015-10-19 2019-02-07 セルマティックス, インコーポレイテッド 卵巣予備能および卵巣機能の低下の結果としての不妊を評価するための方法およびシステム
WO2018141015A1 (en) * 2017-02-01 2018-08-09 Newsouth Innovations Pty Limited Gamete-secreted growth factors
WO2018200820A1 (en) * 2017-04-26 2018-11-01 Celmatix Inc. A measurement system and method for defining and determining an ovarian reserve
CN110564839A (zh) * 2019-08-23 2019-12-13 浙江大学 一种卵巢早衰相关基因全外显子扩增及检测方法
CN111500723A (zh) * 2020-04-28 2020-08-07 广州达康基因技术有限公司 一种用于卵巢早衰基因检测的标志物组合及检测试剂盒
CN112266953B (zh) * 2020-07-27 2022-08-02 广州达康基因技术有限公司 女性卵巢早衰易感基因检测模型及检测试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050638A1 (en) * 1999-02-25 2000-08-31 Auckland Uniservices Limited Diagnosis and therapy of premature ovarian failure
NZ500844A (en) * 2000-05-05 2003-06-30 Agres Ltd Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate

Also Published As

Publication number Publication date
WO2007031590A1 (es) 2007-03-22
WO2007031590A9 (es) 2007-05-31
EP1947195A4 (de) 2009-11-04
EP1947195A1 (de) 2008-07-23
DE602006018183D1 (de) 2010-12-23
EP1947195B1 (de) 2010-11-10
US20100203502A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
ATE487800T1 (de) Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion
BR112013003391A2 (pt) biomarcadores de câncer pancreático e usos dos mesmos
ATE452343T1 (de) Verbesserte vitamin-d-messung
ATE450623T1 (de) Modifikatoren der lichtemission und ihre verwendungen zur detektion, amplifikation und analyse von nukleinsäuren
BRPI0817415B8 (pt) processo e kit para capturar ou concentrar microorganismos
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
WO2020019014A8 (en) Lateral flow assay devices and method of use
BR112014016313A2 (pt) medições precisas de analito para tira de teste eletroquímico com base em característica(s) física(s) detectada(s) da amostra contendo o analito e parâmetros de biossensores derivados
BRPI0515271A (pt) fixação de extremidade de correia para a fixação de uma extremidade de uma correia portadora em um sistema de elevador e método para a fixação de uma extremidade de uma correia portadora em um sistema de elevador
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
WO2005116651A3 (en) Method and device for testing for bence-jones protein
TW200641366A (en) Apparatus, program, and method for substrate inspection
EP2237109A3 (de) Verfahren zur Prüfung und Beurteilung eines Photomaskenrohlings oder eines Zwischenprodukts davon
ATE489622T1 (de) Verfahren zur beurteilung der malignität einer säuger-krebszelle
NZ609824A (en) Immunochromatography devices, methods and kits
HK1149956A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2019139980A8 (en) Methods for measuring analyte and/or protein in biological samples
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
BRPI0518633A2 (pt) processo para estimar os resÍduos provocados por estoques de abastecimento de refinarias
WO2009140390A3 (en) Serum markers for type ii diabetes mellitus
WO2019197543A3 (en) Periodontitis diagnostic methods, uses and kits
WO2008057767A3 (en) Reduction of non-specific binding in immunoassays
ATE495266T1 (de) Verfahren für den nachweis von atp in einer probe mithilfe von lumineszenz und computerprogramm dafür
MX2023003997A (es) Biomarcadores, métodos y composiciones para el tratamiento de la enfermedad autoinmunitaria, que incluye el lupus eritematoso sistémico (les).

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties